Evidence map›Paper›PMID 40905090›Full record

ArticleHaematologica2026

Use of upfront autologous stem cell transplantation in myeloma patients aged >65 years: a population-based study by the Nordic Myeloma Study Group.

Kari Lenita Falck Moore, Samundur Rognvaldsson, Agoston G Szabo, Vilmantė Vaitekėnaitė, Diana Loigom, Anna Genell, Jonathan Thorsen, Jakob N Norgaard, Sigrun Thorsteinsdottir, Dorota Knut-Bojanowska and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Kari Lenita Falck MooreOslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; K.G. Jebsen Center for B cell malignancies, University of Oslo, Oslo, Norway; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger. kari.lenita.falck.moore@sus.no.
Samundur RognvaldssonLandspitali University Hospital, Reykjavik, Iceland; Faculty of Medicine, University of Iceland, Reykjavik.
Agoston G SzaboDepartment of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; Department of Hematology, Vejle Hospital, Vejle, Denmark.
Vilmantė VaitekėnaitėCenter for Hematology, Oncology, and Transfusiology, National Cancer Center Affiliate, Vilnius University Hospital Santaros Klinikos, Vilnius.
Diana LoigomCentre of Haematology, North Estonia Medical Centre Foundation, Tallinn.
Anna GenellRegional Cancer Center of the Western Region, Sahlgrenska University Hospital, Gothenburg.
Jonathan ThorsenCopenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen.
Jakob N NorgaardOslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway; K.G. Jebsen Center for B cell malignancies, University of Oslo, Oslo.
Sigrun ThorsteinsdottirFaculty of Medicine, University of Iceland, Reykjavik, Iceland; Department of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen.
Dorota Knut-BojanowskaDepartment of haematology, Uddevalla hospital, Uddevalla.
Anna LysenOslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo.
Fredrik SchjesvoldOslo Myeloma Center, Department of Hematology, Oslo University Hospital, Oslo.
Valdas PeceliunasCenter for Hematology, Oncology, and Transfusiology, National Cancer Center Affiliate, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania; Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius.
Ain KaareDepartment of Hematology and Bone Marrow Transplant, Tartu University Hospital, Tartu.
Katrin PalkCentre of Haematology, North Estonia Medical Centre Foundation, Tallinn.
Maris ParnatDepartment of Hematology and Bone Marrow Transplant, Tartu University Hospital, Tartu.
Alexander SigurdssonReykjavik Primary Health Care Center, Reykjavik.
Annette J VangstedDepartment of Hematology, Copenhagen University Hospital, Rigshospitalet, Copenhagen.
Cecilie H BlimarkDepartment of Haematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg.
Nordic Myeloma Study Group.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40905090
PMCPMC12862320

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.